| Functional aspect | Evidence summary | Key quantitative details | Primary citations with URLs and publication year |
|---|---|---|---|
| Enzyme identity | Zebrafish **gnptab** (UniProt **Q5RGJ8**) corresponds to **UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase α/β precursor**, the catalytic polypeptide of GlcNAc-1-phosphotransferase in the mannose-6-phosphate pathway; a zebrafish minimal construct from **Q5RGJ8** was used for structural/biochemical analysis and is highly similar to human GNPTAB. (pqac-00000000, pqac-00000001) | Zebrafish construct is **87% sequence identity** to human GNPTAB. (pqac-00000000, pqac-00000001) | Gorelik et al., 2022, PNAS, https://doi.org/10.1073/pnas.2203518119 (pqac-00000000, pqac-00000001) |
| Enzyme name / EC | The enzyme is **GlcNAc-1-phosphotransferase / N-acetylglucosamine-1-phosphotransferase**, **EC 2.7.8.17**, catalyzing the first committed step in M6P biosynthesis on lysosomal hydrolases. (pqac-00000003, pqac-00000004, pqac-00000007) | EC **2.7.8.17**. (pqac-00000003, pqac-00000004) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110 |
| Reaction catalyzed | GNPT transfers **phospho-GlcNAc / GlcNAc-1-phosphate** from **UDP-GlcNAc** to mannose residues on N-linked high-mannose glycans of lysosomal hydrolases, creating a **GlcNAc-P-mannose** intermediate that is later uncovered to M6P by NAGPA/UCE. (pqac-00000003, pqac-00000004, pqac-00000007) | First step of a **2-step** M6P-tagging pathway. (pqac-00000007, pqac-00000021) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Liu et al., 2024, https://doi.org/10.3389/fcimb.2024.1349221 |
| Donor substrate | The donor substrate is **UDP-GlcNAc**, which binds tightly in a deep catalytic cavity in the zebrafish GNPTAB catalytic domain. (pqac-00000001, pqac-00000003) | Requires **Mg2+ or Mn2+** for activity. (pqac-00000001, pqac-00000003) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119 |
| Acceptor substrate | The acceptor is the **6-hydroxyl of mannose** within **high-mannose N-glycans** on lysosomal hydrolases; GNPT can also act on minimal mannose-containing substrates such as **α-methyl-D-mannoside** and even a **single mannose** in biochemical assays. (pqac-00000000, pqac-00000002, pqac-00000005) | Catalytically active on substrate as small as **single mannose**; αMM assay used in zebrafish extracts. (pqac-00000000, pqac-00000002) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110 |
| Product(s) | Immediate product is a **phosphodiester sugar intermediate** (GlcNAc-P-mannose) on the glycan; after uncovering enzyme action, mature **mannose-6-phosphate (M6P)** is generated for receptor-mediated sorting. (pqac-00000004, pqac-00000007, pqac-00000021) | M6P pathway tags most lysosomal hydrolases; LYSET/GNPT perturbation can disrupt tagging of about **70 lysosomal enzymes**. (pqac-00000016) | Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Brauer et al., 2024, https://doi.org/10.1038/s44318-024-00305-z |
| Subunit organization | Native GNPT is a **heterohexamer** composed of **α2β2γ2**; **GNPTAB** encodes the α/β precursor containing catalytic activity, whereas **GNPTG** encodes the auxiliary γ subunit that enhances phosphorylation of subsets of substrates and contributes to recognition. (pqac-00000001, pqac-00000004, pqac-00000007) | Complex reported as ~**400 kDa** in one source and ~**540 kDa** in review-style summaries. (pqac-00000007, pqac-00000005, pqac-00000021) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Liu et al., 2024, https://doi.org/10.3389/fcimb.2024.1349221 |
| Activation / processing | GNPTAB is synthesized as an **inactive α/β precursor** and activated by **Site-1 protease (S1P)** cleavage in the Golgi/TGN at **Lys928-Asp929** (or after Lys928), generating mature α and β subunits; minimal catalytic constructs lacking the intervening region can bypass this requirement experimentally. (pqac-00000000, pqac-00000003, pqac-00000004, pqac-00000006) | Cleavage site at **K928-D929**; catalytic mutation **Asp407** causes ~**500-fold** activity loss; **Asn1151** mutation decreases activity ~**200-fold**. (pqac-00000000, pqac-00000003) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110 |
| Key catalytic determinants | Structural work on zebrafish GNPTAB identified catalytic residues and metal coordination: **His956** likely deprotonates mannose O6, **Arg986** and **Mg1** stabilize phosphate, **Asp408/D407** coordinates metal, and the catalytic site lies in a deep luminal cavity. (pqac-00000000, pqac-00000001, pqac-00000003) | **D407** mutation ~**500-fold** loss; **N1151** mutation ~**200-fold** loss. (pqac-00000000, pqac-00000003) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119 |
| Key domains in GNPTAB | GNPTAB contains a multipart **catalytic domain** plus accessory modules including **DMAP1-binding-like domain**, **Notch/EGF-like repeats**, **immunoglobulin-like domain**, **RRM-like/N-terminal modules**, and an **EF-hand Ca2+-binding domain**; these accessory regions contribute to selective hydrolase recognition. (pqac-00000001, pqac-00000004, pqac-00000024) | Accessory-domain deletion retains catalytic activity but loses lysosomal-vs-nonlysosomal discrimination and γ-binding site. (pqac-00000001) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110 |
| Localization / topology | GNPT functions in the **cis-Golgi**; GNPTAB is membrane-anchored with luminal active sites oriented toward the Golgi lumen, supported by structural topology and colocalization with **GM130**. (pqac-00000001, pqac-00000002, pqac-00000003, pqac-00000007) | GNPTAB precursor contains **4 transmembrane helices** overall in the complex topology context; active sites face Golgi lumen. (pqac-00000003) | Gorelik et al., 2022, https://doi.org/10.1073/pnas.2203518119; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110 |
| Pathway role | GNPTAB initiates **M6P-dependent lysosomal enzyme targeting**, enabling subsequent recognition by **cation-independent/cation-dependent M6P receptors** and delivery of hydrolases to lysosomes; loss of GNPT causes missorting/secretion of lysosomal enzymes and MLII/III pathology. (pqac-00000004, pqac-00000007, pqac-00000021) | Defects can abolish M6P labeling and elevate serum/plasma lysosomal hydrolases; diagnostic studies cite **10-20×** normal enzyme activities as supportive of MLII/III diagnosis. (pqac-00000021, pqac-00000022) | Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Liu et al., 2024, https://doi.org/10.3389/fcimb.2024.1349221; Feng et al., 2024, https://doi.org/10.1186/s12887-024-05223-x |
| Substrate-recognition determinants | Recognition of lysosomal hydrolases depends on **protein tertiary structure**, **specific lysines near N-glycans**, the **DMAP domain** of GNPTAB, and the **MRH mannose-binding domain** of GNPTG. GST-DMAP binds lysosomal hydrolases (cathepsin D, α-iduronidase) but not nonlysosomal glycoproteins. (pqac-00000000, pqac-00000004, pqac-00000005, pqac-00000006) | Recognition can be ~**100-fold** selective for lysosomal cargos; human **K732N** DMAP mutant phosphorylates cathepsin D and α-iduronidase at only **12-15%** of WT efficiency. (pqac-00000002, pqac-00000006) | Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Petrey dissertation excerpt, 2012 (pqac-00000006) |
| Zebrafish-specific functional evidence | In zebrafish gnptab-deficient MLII models, loss of mannose phosphorylation of lysosomal hydrolases causes craniofacial/cartilage, cardiac, otic vesicle, pectoral fin, and motility defects; WT GNPTAB mRNA rescues biochemical and developmental defects, whereas substrate-recognition mutant **K732N** fails to rescue. (pqac-00000002, pqac-00000008, pqac-00000012, pqac-00000015) | WT PT activity in embryos **35-51 pmol/mg/h**; MO knockdown up to **89%** at 4 dpf; partial ~**58%** reduction can still yield largely normal embryos; body length reduced ~**10 ± 3%**; death by **5-6 dpf**. WT rescue ~**75%**; **~76%** remained MLII-like with K732N rescue attempt. (pqac-00000002, pqac-00000012) | Flanagan-Steet et al., 2009, https://doi.org/10.2353/ajpath.2009.090210; Qian et al., 2013, https://doi.org/10.1073/pnas.1308453110; Petrey et al., 2012, https://doi.org/10.1242/dmm.008219 |
| Zebrafish mechanistic phenotypes downstream of loss | gnptab loss in zebrafish alters chondrocyte differentiation and ECM homeostasis: chondrocytes fail to intercalate, are **25% larger**, show high/ectopic **Sox9**, reduced **aggrecan**, sustained **col2a1/type II collagen**, and elevated cathepsin/MMP activity; WT GNPTAB mRNA normalizes cathepsin activity. (pqac-00000008, pqac-00000009, pqac-00000010, pqac-00000013) | GFP+ chondrocyte-enriched cells were ~**8%** and **20%** of dissociated cells at 2 and 3 dpf, with **99.2%** and **99.9%** purity; WT n=**4**, ML-II n=**6** in enzyme assays. (pqac-00000009) | Petrey et al., 2012, https://doi.org/10.1242/dmm.008219; Flanagan-Steet et al., 2009, https://doi.org/10.2353/ajpath.2009.090210 |
| Pharmacologic/genetic rescue in zebrafish model | Inhibition of **cathepsin K** genetically or pharmacologically ameliorates gnptab/MLII cartilage defects and reduces broader protease dysregulation, supporting a mechanistic link between lysosomal mistargeting and extracellular protease-driven pathology. (pqac-00000008, pqac-00000011) | Cathepsin K inhibitor rescue: **13.9%** rescue at **2.5 µM**, **22.2%** at **5 µM**; cathepsin K SB MO gave **15.9% full rescue** and **69.2% partial rescue**; chondrocyte intercalation improved from **6 ± 4%** in MLII toward **60 ± 9%** with co-knockdown vs **85 ± 5%** WT. (pqac-00000011) | Petrey et al., 2012, https://doi.org/10.1242/dmm.008219; Petrey dissertation excerpt, 2012 (pqac-00000011) |
| Recent pathway regulators / current understanding | Recent work places GNPTAB under control of **TMEM251/LYSET/GCAF**, **GOLPH3/GOLPH3L**, and likely **retromer**-dependent Golgi retention/recycling; disruption causes GNPT mislocalization to lysosomes, reduced cleavage/activity, and broad M6P-tagging defects. (pqac-00000016, pqac-00000017, pqac-00000018, pqac-00000023) | LYSET deficiency affects tagging/trafficking of about **70 lysosomal enzymes**; TMEM251 alanine-scan defects scored partly by **<50%** mCTSD threshold. (pqac-00000016, pqac-00000017) | Brauer et al., 2024, https://doi.org/10.1038/s44318-024-00305-z; Yang et al., 2024 preprint, https://doi.org/10.1101/2024.12.05.627003; Tang et al., 2023, https://doi.org/10.4052/tigg.2204.1e |


*Table: This table summarizes the core functional annotation of Danio rerio gnptab (UniProt Q5RGJ8), integrating enzyme chemistry, domains, localization, pathway role, and zebrafish-specific experimental evidence. It also highlights quantitative results and key primary citations useful for downstream gene annotation.*